Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Gennex Laboratories Ltd

NSE: GENNEX · BSE: 531739 · Pharmaceuticals & Biotechnology · 18 announcements

Share price
₹9.99
Market cap
₹242.7 Cr
Revenue (annual)
₹172.7 Cr
Net profit (annual)
₹20.98 Cr
P/E (TTM)
10.3×Sector 47.4×
Promoter holding
23.63%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:45 IST BSE
Board Meeting Date

Gennex Laboratories Board Meeting Date

Gennex Laboratories has announced a board meeting scheduled for September 4, 2026, to discuss the upcoming 41st Annual General Meeting and other business matters.

14:36 IST BSE
Board Meeting Date

Gennex Laboratories Board Meeting Date

Gennex Laboratories scheduled a board meeting for August 14, 2026. The board will review unaudited financial statements for the June 30, 2026 quarter.

17:21 IST BSE
Board Meeting Date

Gennex Laboratories Board Meeting Date

Gennex Laboratories scheduled a board meeting for May 30, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-declaration.